Market Overview

UPDATE: Canaccord Genuity Maintains Buy, $58 PT on Itron as Bullish Outlook Continues

Share:
Related ITRI
Canaccord Getting Constructive On Itron, Upgrades To Buy
Probes Reporter's Latest Updates: Choice Hotels, GlaxoSmithKline, Itron, Kinross Gold And More

Canaccord Genuity maintained its Buy rating and $58 price target on Itron (NASDAQ: ITRI).

Canaccord Genuity stated in the report, "While ‘12 is in transition (restructuring, CEO search, tough compares), the deep product platform (and secular shift toward digital meters) continues to generate solid cash flow and supports our bullish outlook. In sum, we find Itron positioned as perhaps one of the best “value-based” growth stocks in our universe, as the discount to fair market value is the most glaring in memory given the two recent take-outs of key competitors (L+G and Elster), with our math suggesting a theoretical ~$55 price by extrapolating similar multiples." 

ITRI closed at $43.44 on Tuesday.

Latest Ratings for ITRI

DateFirmActionFromTo
Jan 2016WedbushInitiates Coverage onOutperform
Oct 2015Canaccord GenuityUpgradesHoldBuy
Sep 2015OppenheimerInitiates Coverage onPerform

View More Analyst Ratings for ITRI
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Reiteration Pre-Market Outlook Analyst Ratings

 

Related Articles (ITRI)

View Comments and Join the Discussion!

Get Benzinga's Newsletters